It also recruits MDSCs by upregulating CXCL1 and IL-17 expression and pro-tumor Treg/T helper 17 cell responses via IL-6/STAT3 signaling induced by the KRAS oncogene [85]. The gene discussed is STAT3; the disease is neoplasm.